Regulatory B cells (Bregs) identified by the CD19+CD24+CD38+ phenotype are an important immunosuppressive components for myeloma, as they prevent immune effector cells from homing and interacting with targeted tumor cells.25 The gene discussed is CD24; the disease is plasma cell myeloma.